Material Agreements

Black Spade Acquisition III Co entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company, as trustee (effective 2026-01-05).

“· An Investment Management Trust Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee.”

Black Spade Acquisition III Co entered into Warrant Agreement with Continental Stock Transfer & Trust Company, as warrant agent (effective 2026-01-05).

“· A Warrant Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.”

Black Spade Acquisition III Co entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters, including Chardan Capital Markets, LLC (effective 2026-01-05).

“· An Underwriting Agreement, dated January 5, 2026, among the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“ Cohen ”), as representative of the several underwriters, including Chardan Capital Markets, LLC (“ Chardan ” and, together with Cohen, the “ Underwriters ”).”

Bleichroeder Acquisition Corp. II entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters (effective 2026-01-07).

“An Underwriting Agreement, dated January 7, 2026, by and between the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters”

ARROWHEAD PHARMACEUTICALS, INC. entered into Convertible Notes Underwriting Agreement with J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the several underwriters valued at $625,000,000 aggregate principal amount (effective 2026-01-07).

“On January 7, 2026, the Company entered into an underwriting agreement (the “Convertible Notes Underwriting Agreement”) with J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the several underwriters named therein (the “Convertible Notes Underwriters”), to issue and sell (the “Convertible Notes Offering”) $625,000,000 aggregate principal amount of its 0.00% convertible senior notes due 2032”

ARROWHEAD PHARMACEUTICALS, INC. entered into Equity Underwriting Agreement with Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters (effective 2026-01-07).

“On January 7, 2026, Arrowhead Pharmaceuticals, Inc. (the “Company”) entered into an underwriting agreement (the “Equity Underwriting Agreement”) with Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein (collectively, the “Equity Underwriters”), to issue and sell 3,100,776 shares of the Company’s common stock”

WILLIAMS COMPANIES, INC. entered into Thirteenth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-01-08).

“the Thirteenth Supplemental Indenture (the “Thirteenth Supplemental Indenture,” and together with the Base Indenture and the Seventh Supplemental Indenture, the “Indenture”), dated as of January 8, 2026, between the Company and the Trustee”

AGENUS INC amended Amendment Agreement with Ligand Pharmaceuticals Incorporated (effective 2026-01-03).

“On January 3, 2026, Agenus Inc. (the “Company”), Agenus Royalty Fund, LLC and Agenus Holdings 2024, LLC entered into an amendment and release agreement (the “Amendment Agreement”) with Ligand Pharmaceuticals Incorporated (“Ligand”) related to a Purchase and Sale Agreement and related Warrant each previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on May 7, 2024.”

Alaunos Therapeutics, Inc. terminated Engagement Letter dated August 14, 2023 with Cantor Fitzgerald & Co. valued at Termination of engagement letter for strategic transactions advisory; no fees payable upon terminati (effective 2026-01-08).

“On January 8, 2026, the Company delivered written notice to Cantor Fitzgerald & Co. (“Cantor”) terminating, effective immediately, the engagement letter dated August 14, 2023 (the “Engagement Letter”), pursuant to which Cantor had been engaged as the Company’s exclusive financial advisor in connection with the exploration of potential strategic transactions.”

CURIS INC entered into Securities Purchase Agreement with the purchasers named therein valued at up to approximately $80.8 million (effective 2026-01-07).

“On January 7, 2026, Curis, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of (i) 20,195 shares of its Series B convertible non-redeemable preferred stock, par value $0.01 per share (the “Series B Preferred Stock”), (ii) Series A warrants”

CONSTELLATION ENERGY GENERATION LLC entered into Senior Notes valued at $300,000,000 in aggregate principal amount of Floating Rate Senior Notes due 2028, $900,000,000 in a (effective 2026-01-08).

“On January 8, 2026, Constellation Energy Generation, LLC (Constellation) issued and sold $300,000,000 in aggregate principal amount of Floating Rate Senior Notes due 2028 (the Floating Rate Senior Notes), $900,000,000 in aggregate principal amount of 3.900% Senior Notes due 2028 (the 2028 Senior Notes), $750,000,000 in aggregate principal amount of 4.400% Senior Notes due 2031 (the 2031 Senior Notes) and $800,000,000 in aggregate principal amount of 5.875% Senior Notes due 2066 (the 2066 Senior Notes, and collectively with the Floating Rate Senior Notes, the 2028 Senior Notes and the 2031 Senior Notes, the Senior Notes).”

American Well Corp amended Amended and Restated Statement of Work with Elevance Health, Inc. f/n/a/ Anthem Inc. (effective 2026-01-01).

“On January 5, 2026, American Well Corporation (the “Company”) entered into an Amended and Restated Statement of Work (the “SOW”) with Elevance Health, Inc. f/n/a/ Anthem Inc. (“Elevance Health”), effective as of January 1, 2026, replacing the Statement of Work dated January 1, 2023 between the parties, and extending the parties’ partnership pursuant to which the Company operates a white-labelled digital care delivery platform on behalf of Elevance Health under the brand name LiveHealth Online®.”

Netcapital Inc. entered into Asset Purchase Agreement with Iverson Design, LLC valued at 980,000 shares of the Company’s common stock (effective 2026-01-02).

“On January 2, 2026, Netcapital Inc., a Utah corporation (the “Company”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) by and among the Company, Iverson Design, LLC, a Massachusetts limited liability company (the “Seller”), and Michael Iverson, as the Seller’s manager and sole member (collectively, the “Seller Parties”).”

KALA BIO, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2026-01-08).

“On January 8, 2026, KALA BIO, Inc. (the “ Company ”), entered into an At The Market Offering Agreement (the “ Sales Agreement ”) with H.C. Wainwright & Co., LLC (“ Wainwright ”)”

Acushnet Holdings Corp. entered into Subscription and Shareholders’ Agreement with Myre Overseas Corp. and ACL FootJoy Pte. Ltd. (effective 2026-01-06).

“On January 6, 2026, Acushnet Cayman Limited (“Acushnet Cayman”), a limited company incorporated under the laws of the Cayman Islands and a wholly owned subsidiary of Acushnet Holdings Corp. (the “Company”), entered into a Subscription and Shareholders’ Agreement (the “Agreement”) by and among Acushnet Cayman, Myre Overseas Corp. (“Myre”) and ACL FootJoy Pte. Ltd. (“ACL FootJoy”), pursuant to which Acushnet Cayman and Myre (together, the “Shareholders”) formed a joint venture and subscribed for shares in the capital of ACL FootJoy”

SPRUCE BIOSCIENCES, INC. entered into Loan and Security Agreement with Avenue Capital Management II, L.P. and Avenue Venture Opportunities Fund II, L.P. valued at $50.0 million (effective 2026-01-07).

“On January 7, 2026 (the “Closing Date”), Spruce Biosciences, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan and Security Agreement”) and a Supplement to the Loan and Security Agreement (together with the Loan and Security Agreement, the “Loan Agreement”), with Avenue Capital Management II, L.P., as administrative agent and collateral agent (the “Agent”) and Avenue Venture Opportunities Fund II, L.P., as lender (the “Lender”).”

Canopy Growth Corp entered into Exchange Agreement with MMCAP International Inc. SPC valued at C$96,358,375 aggregate principal amount of senior unsecured convertible debentures exchanged for C$5 (effective 2026-01-07).

“Exchange Agreement On January 7, 2026, the Company entered into an Exchange Agreement (the “ Exchange Agreement ”) with MMCAP International Inc. SPC (the “ Investor ”) pursuant to which, among other things, on January 8, 2026 (the “ Exchange Closing Date ”), the Investor delivered to the Company C$96,358,375 aggregate principal amount of senior unsecured convertible debentures of the Company maturing in May 2029 held by the Investor in exchange for (A) the Company issuing to the Investor (i) new senior unsecured convertible debentures of the Company with an aggregate principal amount of C$55,000,000 maturing on July 8, 2031 (the “ Convertible Debentures ”), (ii) 12,731,481 common share purchase warrants (the “ Investor Warrants ” and together with the Loan Warrants, the “ Warrants ”) of the Company, and (iii) 9,493,670 Common Shares (the “ Exchange Shares ”) and (B) a C$10,500,000 cash payment from the Company (collectively, the “ Exchange Transaction ” and together with the Loan Trans”

Canopy Growth Corp entered into Loan and Guaranty Agreement with JGB Collateral LLC, as administrative and collateral agent, and the Lenders valued at US$150,000,000 advanced under senior secured loan in aggregate principal amount of US$162,115,000 (effective 2026-01-08).

“Loan Agreement On January 8, 2026, Canopy Growth Corporation (the “ Company ”) entered into a Loan and Guaranty Agreement (the “ Loan Agreement ”), by and among the Company, as a borrower, certain subsidiaries of the Company party thereto, as borrowers and/or guarantors, the parties identified therein as lenders (the “ Lenders ”), and JGB Collateral LLC, as administrative and collateral agent (the “ Agent ”), pursuant to which, among other things, the Lenders advanced US$150,000,000 pursuant to a senior secured loan in the aggregate principal amount of US$162,115,000 (collectively, the “ Loans ” and such transaction, the “ Loan Transaction ”).”

Crown Electrokinetics Corp. entered into Asset Purchase Agreement with Paramount Infrastructure Corp valued at $2,000,000 (effective 2026-01-02).

“On January 2, 2026 and effective as of January 5, 2026, Crown Fiber Optics Corp., a Delaware corporation (“ Seller ”), a wholly-owned subsidiary of Crown Electrokinetics Corp, a Delaware corporation, entered into an Asset Purchase Agreement (the “ APA ”) with Paramount Infrastructure Corp, a Colorado corporation (“ Buyer ”)”

Star Mountain Lower Middle-Market Capital Corp entered into Note Purchase Agreement valued at $25,000,000 (effective 2026-01-02).

“On January 2, 2026, Star Mountain Lower Middle-Market Capital Corp. (the "Company") entered into a Note Purchase Agreement (the "Note Purchase Agreement") governing the issuance of $25,000,000 in aggregate principal amount of Floating Rate Senior Unsecured Notes due January 15, 2029”

Sky Quarry Inc. terminated Agreement with Varie Asset Management LLC valued at up to $8,125,000 (effective 2026-01-07).

“On January 7, 2026, the Company terminated the purchase agreement (“Agreement”) entered into with Varie Asset Management LLC (“Varie”) on July 9, 2025.”

Beachbody Company, Inc. amended Amendment No. 1 to Credit Agreement with Tiger Finance, LLC, as administrative agent and collateral agent valued at The Amended Credit Agreement amends the financial covenants from the Prior Credit Agreement: maximum (effective 2026-01-07).

“On January 7, 2026 (the “ Amendment Effective Date ”), The Beachbody Company, Inc. (the “ Company ”) entered into an Amendment No. 1 to Credit Agreement (the “ Amended Credit Agreement ”) among the Company, as the Administrative Borrower (as defined therein), the other Borrowers (as defined therein) party thereto, the lenders party thereto, and Tiger Finance, LLC, as administrative agent and collateral agent.”

Janus International Group, Inc. entered into Asset Purchase Agreement with Kiwi II Construction Inc., Kiwi II East Inc., Metal Tech, Inc., certain individuals, and Wayne Woolsey valued at approximately $97.2 million in cash (effective 2026-01-08).

“On January 8, 2026, Janus International Group, LLC (“Janus Core”), a Delaware limited liability company and wholly-owned subsidiary of Janus International Group, Inc. (the “Company”), entered into, and closed the transaction contemplated by, that certain Asset Purchase Agreement, dated as of January 8, 2026 (the “Agreement”) with Kiwi II Construction Inc., a California corporation (“Kiwi Construction”), Kiwi II East Inc., a Tennessee corporation (“Kiwi East”), Metal Tech, Inc., a California corporation (“Metal Tech” and, together with Kiwi Construction and Kiwi East, the “Sellers”), certain individuals (the “Beneficial Owners” and, together with the Sellers, the “Seller Parties”) that owned all of the outstanding equity interests of the Sellers, and Wayne Woolsey, an individual, in his capacity as representative of the Seller Parties.”

VEEA INC. terminated Line of Credit with JP Morgan Chase valued at $14,076,218 (effective 2026-01-05).

“On January 5, 2026, Veea Inc., a Delaware corporation (the “Company”), repaid in full its line of credit (the “Line of Credit”) with JP Morgan Chase (the “Bank”) by making a cash payment to the Bank of $14,076,218, representing the total outstanding principal and interest due as of January 5, 2026. In connection with the repayment, the Line of Credit and all commitments thereunder were terminated.”

VEEA INC. entered into Demand Promissory Note with NLabs Inc valued at $14,100,000 (effective 2026-01-05).

“On January 5, 2026, NLabs Inc, a Delaware corporation (“NLabs”) made an unsecured loan to Veea Inc., a Delaware corporation (the “Company”). NLabs is a principal stockholder of the Company and an affiliate of the Company’s Chief Executive Officer. The loan was in the principal amount of $14,100,000 and evidenced by a Demand Promissory Note (the “Note”). Interest on the Note accrues and is payable at maturity at an annual rate equal to 10%, with interest calculated on the basis of a 365-day year and the actual days elapsed. The Note and accrued interest thereon is payable upon the earlier of March 31, 2026 and demand by NLabs. The Company may prepay the Note, in whole or in part, without penalty at any time.”

Century Therapeutics, Inc. entered into Purchase Agreement with certain institutional accredited investors valued at approximately $135.0 million (effective 2026-01-07).

“On January 7, 2026, Century Therapeutics, Inc. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement (a) (i) 92,030,595 shares (the “Shares”) of common stock, par value $0.0001 per share (“Common Stock”), of the Company, and/or, (ii) pre-funded warrants to purchase 25,360,704 shares of Common Stock (“Pre-Funded Warrants”) and (b) warrants to purchase 58,695,648 shares of Common Stock or Pre-Funded Warrants in lieu thereof (“Common Warrants”, together with the Pre-Funded Warrants, the “Warrants”) at a purchase price of $1.15 per share and accompanying Common Warrant to purchase 0.5 shares of Common Stock or Pre-Funded Warrant and a purchase price of $1.1499 per Pre-Funded Warrant and accompanying Common Warrant to purchase 0.5 shares of Common Stock or Pre-Funded Warrant (the “Private Placemen”

Calumet, Inc. /DE entered into Purchase Agreement with BofA Securities, Inc. as representative of the several initial purchasers named therein valued at $405.0 million aggregate principal amount (effective 2026-01-07).

“On January 7, 2026, Calumet, Inc. (the “Company”), Calumet Specialty Products Partners, L.P. (the “Partnership”), Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), Calumet GP, LLC (the “General Partner”) and certain subsidiary guarantors named therein (the “Subsidiary Guarantors”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc. as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), under which they agreed to sell $405.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended.”

Wellgistics Health, Inc. entered into Placement Agency Agreement with Dawson James Securities, Inc. (the “Placement Agent”) (effective 2026-01-05).

“On January 5, 2026, in connection with the Offering, the Company entered into a placement agency agreement, a copy of which is filed as Exhibit 10.3 to this Current Report on Form 8-K (the “Placement Agency Agreement”) with Dawson James Securities, Inc. (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as the Company’s placement agent in connection with the Offering.”

Wellgistics Health, Inc. entered into Note Purchase Agreement with certain investors (the "Investors") valued at up to $3,125,000 in aggregate principal amount (effective 2026-01-05).

“On January 5, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $3,125,000 in aggregate principal amount (the “Aggregate Principal Amount”) of convertible promissory notes (the “Notes”) (the “Offering”).”

Art Technology Acquisition Corp. entered into Administrative Services Agreement with Art Technology Sponsor, LLC valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“● A Placement Unit Subscription Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC; ● A Placement Securities Subscription Agreement, dated January 5, 2026, between the Company and Clear Street; ● Indemnity Agreements dated January 5, 2026, by and among the Company and each director and executive officer of the Company, a form of which is attached as Exhibit 10.7 to this Current Report; and ● An Administrative Services Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC.”

Art Technology Acquisition Corp. entered into Placement Securities Subscription Agreement with Clear Street valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“s exhibits and incorporated by reference herein: ● An Underwriting Agreement, dated January 5, 2026 (the “ Underwriting Agreement ”), between the Company and Clear Street LLC, as representative of the Underwriters (“ Clear Street ”); ● An Investment Management Trust Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company; ● A Warrant Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company; ● A Registration Rights Agreement, dated January 5, 2026, between the Company and certain security holders of the Company; ● A Letter Agreement, dated January 5, 2026, by and among the Company, its officers and directors and certain of the Company’s security holders; ● A Placement Unit Subscription Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC; ● A Placement Securities Subsc”

Art Technology Acquisition Corp. entered into Placement Unit Subscription Agreement with Art Technology Sponsor, LLC valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“● A Placement Unit Subscription Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC; ● A Placement Securities Subscription Agreement, dated January 5, 2026, between the Company and Clear Street; ● Indemnity Agreements dated January 5, 2026, by and among the Company and each director and executive officer of the Company, a form of which is attached as Exhibit 10.7 to this Current Report; and ● An Administrative Services Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC.”

Art Technology Acquisition Corp. entered into Letter Agreement with the Company, its officers and directors and certain of the Company’s security holders valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“A Letter Agreement, dated January 5, 2026, by and among the Company, its officers and directors and certain of the Company’s security holders;”

Art Technology Acquisition Corp. entered into Registration Rights Agreement with certain security holders of the Company valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“A Registration Rights Agreement, dated January 5, 2026, between the Company and certain security holders of the Company;”

Art Technology Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“● An Investment Management Trust Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company; ● A Warrant Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company; ● A Registration Rights Agreement, dated January 5, 2026, between the Company and certain security holders of the Company; ● A Letter Agreement, dated January 5, 2026, by and among the Company, its officers and directors and certain of the Company’s security holders; ● A Placement Unit Subscription Agreement, dated January 5, 2026, between the Company and Art Technology Sponsor, LLC; ● A Placement Securities Subscription Agreement, dated January 5, 2026, between the Company and Clear Street; ● Indemnity Agreements dated January 5, 2026, by and among the Company and each director and executive officer of the Company, a form of which is attached”

Art Technology Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at A description of the material terms of each of these agreements is included in the Registration Stat (effective 2026-01-05).

“An Investment Management Trust Agreement, dated January 5, 2026, between the Company and Continental Stock Transfer & Trust Company;”

Art Technology Acquisition Corp. entered into Underwriting Agreement with Clear Street LLC valued at Gross proceeds of $220,000,000 from IPO of 22,000,000 Units (effective 2026-01-05).

“An Underwriting Agreement, dated January 5, 2026 (the “ Underwriting Agreement ”), between the Company and Clear Street LLC, as representative of the Underwriters (“ Clear Street ”);”

BION ENVIRONMENTAL TECHNOLOGIES INC amended Second Forbearance Agreement with Bion Loan Group (BLG) (effective 2025-07-15).

“On January 8, 2026, the Bion Loan Group (BLG) informed Bion it was extending the maturity date of its Convertible Promissory Note’s Second Forbearance Agreement, with an effective date of July 15, 2025 (see 8-K filed July 24, 2025), under the same terms and conditions (including the collateral sharing agreement), until June 30, 2026.”

VOLITIONRX LTD amended Amended SPA with Lind Global Asset Management XII LLC valued at $2,000,000 (effective 2026-01-07).

“On January 7, 2026, VolitionRx Limited (the “Company”) entered into an amended and restated securities purchase agreement (the “Amended SPA”) with Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”). Under the Amended SPA, within ten business days of signing, and subject to the satisfaction of certain closing conditions, we will receive $2,000,000 in funding from Lind”

VORNADO REALTY LP amended 2029 Revolving Credit Facility valued at $1.0 billion (effective 2026-01-07).

“VRLP also concurrently entered into an amendment and increased the commitment amount under its other unsecured revolving credit facility that matures in April 2029 (as fully extended) (the “2029 Revolving Credit Facility” and together with the 2031 Revolving Credit Facility, the “Revolving Credit Facilities”) from $915 million to $1.0 billion.”

VORNADO REALTY LP amended Term Loan valued at $850 million (effective 2026-01-07).

“On January 7, 2026, VRLP also amended and extended its term loan (as amended, extended and restated, the “Term Loan”), extending the maturity from December 2027 to February 2031 (as fully extended) and increasing the loan amount to $850 million from $800 million.”

VORNADO REALTY LP amended 2031 Revolving Credit Facility (effective 2026-01-07).

“On January 7, 2026, Vornado Realty L.P. (“VRLP”), the operating partnership through which Vornado Realty Trust (“Vornado”) conducts its business, amended and extended the maturity of one of its revolving credit facilities (as amended, extended and restated, the “2031 Revolving Credit Facility”), from December 2027 (as fully extended) to February 2031 (as fully extended).”

Greystone Housing Impact Investors LP entered into Loan Agreement with BankUnited, N.A. valued at up to $84,000,000 (effective 2025-12-31).

“On December 31, 2025, GHI South Carolina Holdings LLC, GHI South Carolina Century Plaza LLC, GHI South Carolina Sondrio LLC, GHI South Carolina Vietti LLC, and GHI South Carolina Windsor LLC (collectively, the “Borrower”), all of which are subsidiaries of Greystone Housing Impact Investors LP (the “Partnership”), entered into a Loan Agreement (the “Loan Agreement”) of up to $84,000,000 with the administrative agent, sole lead arranger and sole bookrunner, BankUnited, N.A (as “Administrative Agent”).”

SPECTRAL CAPITAL Corp entered into Binding Term Sheet with Intermatica S.p.A. valued at issuance of 5,000,000 shares of the Company’s common stock (effective 2026-01-04).

“On January 4, 2026 Spectral Capital Corporation, a Nevada corporation (the “Company”), entered into a Binding Term Sheet (the “Term Sheet”) with Intermatica S.p.A., a società per azioni organized under the laws of the Republic of Italy (“Intermatica”), setting forth the principal terms and conditions pursuant to which the Company intends to acquire 100% of the issued and outstanding equity interests of Intermatica”

CONSTELLATION ENERGY GENERATION LLC entered into Registration Rights Agreement with certain of the former stockholders of Calpine who received shares of Stock Consideration (effective 2026-01-07).

“On January 7, 2026, in connection with the closing of the Mergers (as defined below), CEG Parent entered into a registration rights agreement (the “Registration Rights Agreement”) with certain of the former stockholders of Calpine who received shares of Stock Consideration (as defined below) in the Mergers, each of whom is listed on the signature pages thereto (the “RRA Parties”), pursuant to which the RRA Parties will have certain customary demand, “piggy-back” and shelf registration rights relating to the shares of Stock Consideration received by such RRA Parties as a result of the Mergers.”

Archrock, Inc. entered into Purchase Agreement with J.P. Morgan Securities LLC, as representative of the initial purchasers valued at $800,000,000 aggregate principal amount of 6.000% Senior Notes due 2034 (effective 2026-01-06).

“On January 6, 2026, Archrock Services, L.P. (“Archrock Services”) and Archrock Partners Finance Corp., a wholly owned subsidiary of Archrock Partners, L.P., (together with Archrock Services, the “Issuers”, and Archrock, Inc., as parent guarantor (the “Company”), and the other subsidiary guarantors thereto (together with Company, the “Guarantors”), entered into a purchase agreement (the “Purchase Agreement”) with J.P. Morgan Securities LLC, as representative of the initial purchasers listed in Schedule 1 thereto (the “Initial Purchasers”), with respect to an upsized private offering (the “Offering”) by the Issuers of $800,000,000 aggregate principal amount of 6.000% Senior Notes due 2034 (the “Notes”) of the Issuers, along with the related guarantees (the “Guarantees”) of the Notes.”

Venus Concept Inc. amended Twenty Third Bridge Loan Amendment with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP (effective 2025-12-31).

“On December 31, 2025, the Loan Parties entered into a Twenty Third Bridge Loan Amendment Agreement with the Lenders (the “Twenty Third Bridge Loan Amendment”).”

Venus Concept Inc. entered into Consent Agreement with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP (effective 2025-12-31).

“On December 31, 2025, Venus Concept Inc. (the “Company”), Venus Concept USA, Inc., a wholly-owned subsidiary of the Company (“Venus USA” or “Borrower”), Venus Concept Canada Corp., a wholly-owned Canadian subsidiary of the Company (“Venus Canada”), and Venus Concept Ltd., a wholly-owned Israeli subsidiary of the Company (“Venus Israel” and together with the Company, Venus USA and Venus Canada, the “Loan Parties”), entered into a Consent Agreement with Madryn Health Partners, LP (“Madryn”) and Madryn Health Partners (Cayman Master), LP (“Madryn Cayman,” and together with Madryn, the “Lenders” or the “Holders”) (the “Consent Agreement”).”

PROSPER MARKETPLACE, INC entered into Third Amendment to the First Amended and Restated Program Agreement with Coastal Community Bank valued at Reduces program fee, extends term to December 31, 2027, grants exclusivity rights, increases receiva (effective 2025-12-31).

“On December 31, 2025, Prosper Marketplace, Inc. (the “Company”) entered into a Third Amendment (the “Third Amendment”) to the First Amended and Restated Program Agreement dated August 16, 2023 (as further amended and restated, the “Agreement”) with Coastal Community Bank (“Coastal”), that governs the Company’s partnership with Coastal through which eligible consumers are extended unsecured credit through Prosper-branded credit cards. Defined terms used herein and not defined shall have the meaning set forth in the Agreement. The Third Amendment, among other things, reduces the program fee paid by the Company to Coastal, extends the term of the Agreement through December 31, 2027, and grants Coastal certain exclusivity rights subject to the terms and conditions set forth therein.”

RANGE IMPACT, INC. entered into Option Agreement with MRR CNG, LLC valued at $500,000 (effective 2025-12-31).

“On December 31, 2025, Range Bluegrass and MRR CNG, LLC, a Connecticut limited liability company engaged in the business of waste sorting and recycling for residential and commercial customers throughout the eastern United States (“MRR”), entered into an Option Agreement (“MRR Option Agreement”) pursuant to which Range Bluegrass, subject to the satisfaction of certain conditions set forth in the Option Agreement and in consideration of the payment of $500,000 (the “Option Fee”), granted MRR an option to purchase approximately 1,500 acres of the land purchased by Range Bluegrass (the “MRR Option”) pursuant to the Bluegrass PSA described above in this Item 1.01 (the “Option Property”).”